Latest Morning Briefing Stories
“He’s a little bit of an alarmist — that’s OK,” President Donald Trump said of his top infectious disease expert. Despite recent criticisms from a few fellow administration officials, Dr. Anthony Fauci continues to urge Americans to take more precautions to stem the coronavirus outbreak.
Opinion writers weigh in on these public health issues and others.
Pandemic-related nursing home news from Texas, Georgia, Virginia, Connecticut and Massachusetts.
New research finds evidence that racial and ethnic minorities in the U.S. have experienced increased incidents of discrimination during the pandemic. Other examples of race-based disparities in the health system are also reported.
Officials raise concerns that hospitals may hit a breaking point if the trajectory of ever-growing caseloads doesn’t change. Plus, a look at the effect of the coronavirus surge on hospitals in Georgia and school nurses in Texas.
An NPR analysis finds that many surgical masks, most imported, tout FDA certificates that don’t have any regulatory meaning. Often the products don’t meet safety standards for health care workers. Meanwhile, more big chains in the U.S. announce mask requirements.
The drugs include antibiotics and a steroid that has been shown to be effective in treating the coronavirus. Also, a new firm will look into making antibodies to fight the disease.
The latest science and research news includes: A $1.6 billion government contract to a vaccine developer explained (Bill Gates figures in the tale); and a new approach to give people temporary immunity from COVID.
The Centers for Medicare & Medicaid Services granted the Joint Commission approval to accredit for only two years, rather than the maximum of six, citing concerns about surveyor performance and comparability of the Joint Commission’s survey process to what CMS uses.
With the U.S. coronavirus system again under strain, the Centers for Disease Control and Prevention is expected to release guidelines saying that coronavirus patients don’t need to be tested again — after symptoms clear — in order to prove they are no longer contagious.
A Trump administration plan to have hospitals bypass the normal repository of its data, the Centers for Disease Control and Prevention, has left hospitals confused, governors pushing back and the public without crucial information about the COVID epidemic.
Intelligence agencies in the U.S., Britain and Canada say they see evidence that Russian hackers are attempting to obtain coronavirus vaccine research. The Russian unit supposedly goes by the name “Cozy Bear.”
Global pandemic developments are reported out of Russia, Hong Kong, Mexico, Brazil, Colombia, France, Australia and other nations.
Initially, medical experts thought Type A blood was a risk factor while Type O was less so. Other public health news on COVID-19 is on a public disconnect, children’s health, employees, vacations, mental health, induced comas, staying safe and partying, as well.
A Rockefeller Foundation report suggests “America faces an impending disaster” if the testing system for the virus is not solved. Evidence of its failure abounds.
Some patients have been stranded in emergency rooms while others have to be transferred between hospitals as doctors frantically search for open beds. Meanwhile, a new report finds that before this latest surge, many hospitals were able to restore their operations to nearly pre-COVID levels.
The Trump administration announced this week that hospitals should now report data about coronavirus patients, supplies and bed capacity directly to the Department of Health and Human Services, rather than the Centers for Disease Control and Prevention. In other health industry news, Georgia revised its request for changes to the insurance marketplace, and doctors and employers team up to offer a new health care payment model.
The latest pharma research updates: Another hydroxychloroquine evaluation; AbbiVie extends its monopoly on pricey cancer drug; and research on radiation and COVID.
As researchers move quickly to develop a vaccine, other researchers raise questions about its delivery method and its safe use with pregnant women.
Former President Barack Obama criticizes the government response to the epidemic, while House Democrats push to probe federal government largess to companies with ties to the Trump administration.